Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACH-126,443 in Treatment-Naive Chronic Hepatitis B
NCT00034359Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Feb 2002
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of elvucitabine in Chronic Hepatitis B (CHB), sponsored by Alexion Pharmaceuticals. Started Feb 2002; status: completed.
02
Drugs
elvucitabine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00034359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034359.